Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1983-07-29 to 1983-11-14
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1983
Report date:
1983

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
not specified
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
4-hydroxy-2,2,6,6-tetramethylpiperidinoxyl
EC Number:
218-760-9
EC Name:
4-hydroxy-2,2,6,6-tetramethylpiperidinoxyl
Cas Number:
2226-96-2
Molecular formula:
C9H18NO2
IUPAC Name:
2,2,6,6-tetramethylpiperidine-1,4-diol
Test material form:
solid: flakes

Test animals

Species:
rat
Strain:
other: Tif:RAIf(SPF); F3 crosses of RII1/Tif x RII 2/Tif
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: CIBA-GEIGY Ltd. Tierfarm, 4334 Sisseln, Switzerland
- Age at study initiation: 7 - 8 weeks
- Weight at study initiation: 166 - 226 g
- Fasting period before study: yes, overnight prior to dosing
- Housing: in groups of 5 in Macrolon cages type IV
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: not specified

ENVIRONMENTAL CONDITIONS
- Temperature: 22 ±3°C
- Humidity: 55 ±15%
- Air changes: 15 per hr
- Photoperiod: 12 hrs dark / 12 hrs light

IN-LIFE DATES: From: 20. Sept. 1983 To: 06. Oct. 1983

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Remarks:
(distilled)
Details on oral exposure:
VEHICLE
- Purity: distilled water

MAXIMUM DOSE VOLUME APPLIED: 20 mL / kg body weight
Doses:
5000 and 2000 mg/kg bw (Sep. 20, 1983)
1000 and 500 mg/kg bw (Sep. 22, 1983)
No. of animals per sex per dose:
5 male and 5 female (total: 40 rats)
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days or until all symptoms have disappeared, whichever lasts longer
- Frequency of observations: twice daily on workdays (a.m. and p.m.); once daily on weekends (a.m.)
- Frequency of weighing: on days 1, 7, 14 and at death
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, daily
Statistics:
Body weight: group means & standard deviations
LD50 and the 95% confidence limit: Logit method (J. Berkson, J. Am. Stat. Ass., 39. 357-65, 1944)

Results and discussion

Effect levelsopen allclose all
Sex:
male/female
Dose descriptor:
LD50
Effect level:
1 053 mg/kg bw
Based on:
test mat.
95% CL:
834 - 1 375
Sex:
male
Dose descriptor:
LD50
Effect level:
953 mg/kg bw
Based on:
test mat.
95% CL:
574 - 1 451
Sex:
female
Dose descriptor:
LD50
Effect level:
1 155 mg/kg bw
Based on:
test mat.
95% CL:
784 - 2 194
Mortality:
500 mg/kg bw: 0 (males); 0 (females)
1000 mg/kg bw: 2 within 2 h and 1 on day 1 (males); 1 within 2 h (females)
2000 mg/kg bw: 3 within 1 h and 2 within 2 h (males); 3 within 1 h, 1 within 2 h and 1 on day 1 (females)
5000 mg/kg bw: 5 within 1h (males); 5 within 1h (females)

Surviving animals recovered within 9 days.
Clinical signs:
other: Dyspnoea, exophthalmus, ruffled fur and curved body position. In addition: Ventral and lateral body position, tonic-clonic convulsions and sedation (in all dose groups: dyspnea and convulsions, the latter for up to 5h past dose, incl. non-moribund animals
Gross pathology:
No findings, some isolated cases of spotted edematous lungs.

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria
Conclusions:
The acute oral LD50 toxicity of 4-Hydroxy TEMPO was tested in a standard OECD 401 guideline study. An LD50 of 1053 mg/kg bw was determined.